Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Annelise Roennow"'
Autor:
Ilaria Galetti, Maureen Sauve, Catarina Leite, Joep Welling, Martina Gahlemann, Annelise Roennow, Robert J Riggs, Ann Tyrrell Kennedy, Edith Brown, Alex Gonzalez, Alexandra Paula Portales Guiraud, François Houÿez, Rob Camp, Annie Gilbert, Lizette Moros, Jose Luis Luna Flores, Friedrich Schmidt, Wiebke Sauter, Henrik Finnern
Publikováno v:
BMJ Open, Vol 10, Iss 12 (2020)
Introduction Transparent collaborations between patient organisations (POs) and clinical research sponsors (CRS) can identify and address the unmet needs of patients and caregivers. These insights can improve clinical trial participant experience and
Externí odkaz:
https://doaj.org/article/90c0fae509b94a35b5a69e0ab34db997
Autor:
Mike O Becker, Gunnel Sandqvist, Tore K Kvien, Marco Matucci-Cerinic, Roger Hesselstrand, Patricia Carreira, László Czirják, Rucsandra Dobrota, Cosimo Bruni, Yannick Allanore, Otylia Kowal-Bielecka, Annelise Roennow, A. Garaiman, Christopher P. Denton, Ana Maria Gheorghiu, Rudolf Debelak, Joseph O. Sexton, Carina Mihai, Oliver Distler, Turid Heiberg, Ulf Mueller-Ladner, Ann Tyrrell Kennedy, Kim Fligelstone
ObjectivesPatient-reported outcome measures (PROMs) are important for clinical practice and research. Given the high unmet need, our aim was to develop a comprehensive PROM for systemic sclerosis (SSc), jointly with patient experts.MethodsThis Europe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cc88951f76e0571d33442ea69a4015d
https://www.zora.uzh.ch/id/eprint/210236/
https://www.zora.uzh.ch/id/eprint/210236/
Autor:
A. Kennedy, I. Galetti, E. Brown, Annelise Roennow, Maureen Sauve, Joep Welling, Wiebke Sauter, R. J. Riggs, A. Gilbert, Henrik W. Finnern, Martina Gahlemann
Publikováno v:
Annals of the Rheumatic Diseases. 80:1033.1-1033
Background:The SENSCIS® trial (2015–18) was a large clinical trial (n=576) investigating the efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease.1 The clinical research sponsors (CRS) collabor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::934589f4d8f7fe2798530c37b9b3c4a5
https://doi.org/10.1136/annrheumdis-2021-eular.1847
https://doi.org/10.1136/annrheumdis-2021-eular.1847
Autor:
Ann Tyrrell Kennedy, François Houÿez, Maureen Sauve, L. Moros, Annie Gilbert, Alexandra Paula Portales Guiraud, Annelise Roennow, Catarina Leite, Rob Camp, Jose Luis Flores, Edith Brown, Martina Gahlemann, Ilaria Galetti, Henrik W. Finnern, Alex Gonzalez, Joep Welling, Friedrich Schmidt, Wiebke Sauter, Robert J Riggs
Publikováno v:
BMJ Open
BMJ Open, Vol 10, Iss 12 (2020)
BMJ Open, Vol 10, Iss 12 (2020)
Introduction Transparent collaborations between patient organisations (POs) and clinical research sponsors (CRS) can identify and address the unmet needs of patients and caregivers. These insights can improve clinical trial participant experience and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5711fa958b3b63e100c5bb81dde5c4c1
https://doi.org/10.1136/bmjopen-2020-039473
https://doi.org/10.1136/bmjopen-2020-039473